In vitro synergism of fluconazole and Baicalein against clinical isolates of Candida albicans resistant to fluconazole

Biological and Pharmaceutical Bulletin

Volumn 31, Issue 12, 2008, Pages 2234-2236

  Huang, Shan ^a   Cao, Ying Ying ^a   Dai, Bao Di ^b   Sun, Xuan Rong ^a   Zhu, Zhen Yu ^a   Cao, Yong Bing ^a   Wang, Yan ^a   Gao, Ping Hui ^a   Jiang, Yuan Ying ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Baicalein; Candida albicans; Drug resistance; Fluconazole; Synergism

Indexed keywords

BAICALEIN; FLUCONAZOLE; RHODAMINE 6G;

ANTIFUNGAL ACTIVITY; ANTIFUNGAL RESISTANCE; ARTICLE; CANDIDA ALBICANS; CONTROLLED STUDY; DRUG POTENTIATION; FUNGUS GROWTH; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN;

ANTIFUNGAL AGENTS; CANDIDA ALBICANS; CANDIDIASIS; DRUG RESISTANCE, FUNGAL; FLAVANONES; FLUCONAZOLE; FLUORESCENT DYES; GLUCOSE; KINETICS; MICROBIAL SENSITIVITY TESTS; RHODAMINES;

EID: 57349086304     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.31.2234     Document Type: Article

References (25)

1. Anaissie E. J., Rex J. H., Uzun O., Vartivarian S., Am. J. Med., 104, 238-245 (1998).
2. Gil-Lamaignere C., Muller F. M., Int. J. Antimicrob. Agents, 23, 520-523 (2004).
3. Quan H., Cao Y. Y., Xu Z., Zhao J. X., Gao P. H., Qin X. F., Jiang Y. Y., Antimicrob. Agents Chemother., 50, 1096-1099 (2006).
4. Van Leyen K., Kim H. Y., Lee S. R., Jin G., Arai K., Lo E. H., Stroke, 37, 3014-3018 (2006).
5. Lapchak P. A., Maher P., Schubert D., Zivin J. A., Neuroscience, 150, 585-591 (2007).
6. Lin H. Y., Shen S. C., Lin C. W., Yang L. Y., Chen Y. C., Biochim. Biophys. Acta, 1773, 1073-1086 (2007).
7. Chang W. T., Shao Z. H., Yin J. J., Mehendale S., Wang C. Z., Qin Y., Eur. J. Pharmacol., 566, 58-66 (2007).
8. Ishige K., Schubert D., Sagara Y., Free Radic. Biol. Med., 30, 433-446 (2001).
9. Chang P. C., Li H. Y., Tang H. J., Liu J. W., Wang J. J., Chuang Y. C., J. Microbiol. Immunol. Infect., 40, 56-61 (2007).
10. Wu J. A., Attele A. S., Zhang L., Yuan C. S., Am. J. Chin. Med., 29, 69-81 (2001).
11. Yang D., Hu H., Huang S., Zhong Yao Cai, 23, 272-274 (2000).
12. Marr K. A., White T. C., van Burik J. A., Bowden R. A., Clin. Infect. Dis., 25, 908-910 (1997).
13. Marr K. A., Lyons C. N., Rustad T. R., Bowden R. A., White T. C., Antimicrob. Agents Chemother., 42, 2584-2589 (1998).
14. Marr K. A., Lyons C. N., Ha K., Rustad T. R., White T. C., Antimicrob. Agents Chemother., 45, 52-59 (2001).
15. National Committee for Clinical and Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts: Approved Standard M27-A. NCCLS, Wayne, PA, U.S.A. (1997).
16. Odds F. C., J. Antimicrob. Chemother., 52, 1-5 (2003).
17. Chen H. H., Hong H. J., Chou Y. H., Cheng T. H., Chen J. J., Lin H., Planta Med., 72, 1318-1321 (2006).
18. Chow J. M., Shen S. C., Wu C. Y., Chen Y. C., Apoptosis, 11, 1999-2011 (2006).
19. Fujita M., Shiota S., Kuroda T., Hatanok T., Yoshida T., Mizushima T., Tsuchiya T., Microbiol. Immunol., 49, 391-396 (2005).
20. Chang P. C., Li H. Y., Tang H. J., Liu J. W., Wang J. J., Chuang Y. C., J. Microbiol. Immunol. Infect., 40, 56-61 (2007).
21. Sanglard D., Kuchler F., Ischer J. L., Pagani M., Bille J., Antimicrob. Agents Chemother., 39, 2378-2386 (1995).
22. Kitagawa S., Nabekura T., Takahashi T., Nakamura Y., Sakamoto H., Tano H., Hirai M., Tsukahara G., Biol. Pharm. Bull., 28, 2274-2278 (2005).
23. Lupetti A., Danesi R., Campa M., Del Tacca M., Kelly S., Trends Mol. Med., 8, 76-81 (2002).
24. Perea S., Lopez-Ribot J. L., Kirkpatrick W. R., McAtee R. K., Santillan R. A., Martinez M., Calabrese D., Sanglard D., Patterson T. F., Antimicrob. Agents Chemother., 45, 2676-2684 (2001).
25. Yan L., Zhang J. D., Cao Y. B., Gao P. H., Jiang Y. Y., J. Proteome Res., 6, 2248-2256 (2007).